Santen Pharmaceutical Co., Ltd.

SNPHF · OTC
Analyze with AI
3/31/2025
3/31/2024
3/31/2023
3/31/2022
Assets
Cash & Equivalents$92,997$94,582$57,903$83,014
Short-Term Investments$997$379$774$1,293
Receivables$71,759$90,539$107,165$99,591
Inventory$51,590$43,185$39,352$37,141
Other Curr. Assets$6,957$7,454$8,132$8,387
Total Curr. Assets$224,300$236,139$213,326$229,426
Property Plant & Equip (Net)$72,954$71,576$66,173$56,287
Goodwill$8,242$8,303$7,385$13,715
Intangibles$67,225$75,516$88,924$116,502
Long-Term Investments$26,539$24,406$36,585$40,944
Tax Assets$10,017$0$2,810$3,103
Other NC Assets$1$19,759$5,976$0
Total NC Assets$184,978$199,560$207,853$230,551
Other Assets-$1$0$0-$1
Total Assets$409,277$435,699$421,179$459,976
Liabilities
Payables$38,989$43,531$44,945$41,185
Short-Term Debt$3,289$2,748$3,056$13,965
Tax Payable$2,239$5,127$6,745$4,198
Deferred Revenue$0$0-$3,056-$13,965
Other Curr. Liab.$42,320$41,390$37,814$50,438
Total Curr. Liab.$86,837$92,796$89,504$95,821
LT Debt$0$0$28,198$12,677
Deferred Rev, NC$0$738-$28,198-$12,677
Deferred Tax Liab, NC$2,606$1,377$1,592$2,526
Other NC Liab.$34,653$35,419$36,786$24,785
Total NC Liab.$37,259$37,534$38,378$27,311
Other Liabilities$0$0$0$0
Cap. Leases$3,015$2,694$2,811$3,029
Total Liabilities$124,096$130,330$127,882$123,132
Equity
Pref Stock$0$0$0$0
Common Stock$8,806$8,777$8,702$8,672
Retained Earnings$228,291$240,029$238,071$290,477
AOCI$40,509$48,413$37,781$29,686
Other Equity$8,636$8,836$9,425$8,652
Total Equity$286,242$306,055$293,979$337,488
Supplemental Information
Minority Interest-$1,061-$685-$683-$645
Total Liab. & Tot. Equity$409,277$435,699$421,861$460,620
Net Debt-$89,708-$91,834-$26,649-$56,372
Santen Pharmaceutical Co., Ltd. (SNPHF) Financial Statements & Key Stats | AlphaPilot